Prospective application of our novel prognostic index in the treatment of anaplastic thyroid carcinoma

Surgery

Volumn 150, Issue 6, 2011, Pages 1212-1219

  Orita, Yorihisa ^a   Sugitani, Iwao ^b   Amemiya, Takeshi ^c   Fujimoto, Yoshihide ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c ANJO KOSEI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEMITHYROIDECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC INDEX; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; RETROSPECTIVE STUDY; SUBTOTAL THYROIDECTOMY; SURVIVAL RATE; SURVIVAL TIME; THYROID CARCINOMA; THYROIDECTOMY; TRACHEOSTOMY; VALIDITY;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 82755182419     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.09.005     Document Type: Article

References (20)

1. T. Yau, C.Y. Lo, R.J. Epstein, A.K. Lam, K.Y. Wan, and B.H. Lang Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy Ann Surg Oncol 15 2008 2500 2505
2. J. Chen, J.D. Tward, D.C. Shrieve, and Y.J. Hitchcock Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002 Am J Clin Oncol 31 2008 460 464
3. E. Kebebew, F.S. Greenspan, O.H. Clark, K.A. Woeber, and A. McMillan Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors Cancer 103 2005 1330 1335 (Pubitemid 40410726)
4. I. Sugitani, N. Kasai, Y. Fujimoto, and A. Yanagisawa Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid World J Surg 25 2001 617 622 (Pubitemid 32441436)
5. C. Hedinger, E.D. Williams, and L.H. Sobin Histological typing of thyroid tumours The WHO international histological classification of tumours 2nd rev. edition 1988 Springer-Verlag Berlin
6. K.T. Robbins, G. Clayman, P.A. Levine, J. Medina, R. Sessions, and A. Shaha Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery Arch Otolaryngol Head Neck Surg 128 2002 751 758 (Pubitemid 34755299)
7. Y. Wang, R. Tsang, S. Asa, B. Dickson, T. Arenovich, and J. Brierley Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens Cancer 107 2006 1786 1792 (Pubitemid 44582947)
8. T. Higashiyama, Y. Ito, M. Hirokawa, M. Fukushima, H. Inoue, and M. Kihara Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma Thyroid 20 2010 7 14
9. T. Kim, Y. Yoo, D.Y. Kang, H. Suh, M.K. Park, and K.J. Park Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystin Int J Oncol 34 2009 1353 1362
10. H. Noguchi, H. Yamashita, T. Murakami, K. Hirai, Y. Noguchi, and J. Maruta Successful treatment of anaplastic thyroid carcinoma with a combination of oral valproic acid, chemotherapy, radiation and surgery Endocrine J 56 2009 245 249
11. B.A. Schiff, A.B. McMurphy, S.A. Jasser, M.N. Younes, D. Doan, and O.G. Yigitbasi Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer Clin Cancer Res 10 2004 8594 8602 (Pubitemid 40053427)
12. A.M. Tsimberidou, C. Vaklavas, S. Wen, D. Hong, J. Wheler, and C.S. Ng Phase I clinical trials in 56 patients with thyroid cancer: the M.D. Anderson Cancer Center experience J Clin Endocrinol Metab 94 2009 4423 4432
13. B. Mclver, I.D. Hay, D.F. Giuffrida, C.E. Dvorak, C.S. Grant, and G.B. Thompson Anaplastic thyroid carcinoma: a 50-year experience at a single institution Surgery 130 2001 1028 1034 (Pubitemid 34014569)
14. A.T. Swaak-Kragten, J.H.W. De Wilt, P.I.M. Schmitz, M. Bontenbal, and P.C. Vevendag Multimodality treatment for anaplastic thyroid carcinoma treatment outcome in 75 patients Radiother Oncol 92 2009 100 104
15. S. Shimoyama, T. Konishi, M. Kawahara, M. Kaminishi, A. Ito, and K. Hojo Pre-operative chemoradiation therapy with 5-fluorouracil and low-dose daily cisplatin for esophageal cancer: a preliminary report Jpn J Clin Oncol 29 1999 132 136
16. M. Yano, T. Tsujinaka, H. Shiozaki, M. Inoue, Y. Doki, and M. Yamamoto Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus J Surg Oncol 70 1999 25 32 (Pubitemid 29061991)
17. Tanaka K, Sugitani I. A novel chemo-radiotherapy with low dose daily cisplatin, 5-FU and doxorubicin for anaplastic thyroid carcinoma: a preliminary report. 12th Congress of the Asian Association of Endocrine Surgeons, March 23-24, 2010, Tokyo, Japan.
18. M. Troch, O. Koperek, C. Scheuba, K. Dieckmann, M. Hoffmann, and B. Niederie High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel J Clin Endocrinol Metab 95 2010 E54 E57
19. A.R. Shaha Airway management in anaplastic thyroid carcinoma Laryngoscope 118 2008 1195 1198
20. Y. Ito, T. Higashiyama, M. Hirokawa, M. Fukushima, H. Inoue, and T. Yabuta Investigation of the validity of UICC stage grouping of anaplastic carcinoma of the thyroid Asian J Surg 32 2009 47 50